The Australian Leukodystrophy Clinical and Research Program works closely with clinicians, researchers, advocacy representatives, and industry leaders around the world to promote new research projects and share scientific discoveries.
Our team is part of the Global Leukodystrophy Initiative, an international consortium determined to understand these conditions better and improve the lives of affected patients and their families.
Leukodystrophy Natural History Studies
Our team are currently working with the Leukodystrophy Centre at the Children’s Hospital of Philadelphia on a number of natural history studies for specific leukodystrophies. A natural history study collects specific health information in order to understand how a specific medical condition or disease develops and how to treat it.
Vanishing White Matter Disease Research
Associate Professor Lezanne Ooi is an NHMRC Boosting Dementia Research Leadership Fellow and Group Leader of the Neurodevelopment and Neurodegeneration Lab. She established her lab in the Illawarra Health and Medical Research Institute and the University of Wollongong in 2012. Her research speciality is neuroscience. Her lab uses cells from Vanishing White Matter Disease patients to understand disease processes and to identify new drugs.